Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 19 April 2011
Vol. 4, Issue 169, p. pe20
[DOI: 10.1126/scisignal.2001917]

PERSPECTIVES

How ITAMs Inhibit Signaling

Lionel B. Ivashkiv*

Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, 535 East 70th Street, New York, NY 10021, USA.

Abstract: Immunoreceptor tyrosine-based activation motifs (ITAMs) are used by multiple receptors to activate immune cells. However, ITAM-associated receptors can have paradoxically inhibitory effects, which have been implicated in regulation of inflammatory responses, but mechanisms of inhibitory signaling are poorly understood. New evidence shows that low avidity ligation of the ITAM-associated immunoglobulin A receptor FcαRI (transient engagement of small numbers of FcαRIs) results in translocation of FcαRI and the associated inhibitory Src homology 2 (SH2) domain–containing phosphatase–1 (SHP-1) to membrane lipid rafts. Subsequent ligation of activating receptors results in their colocalization with FcαRI and SHP-1 and trafficking to an inhibitory intracellular compartment termed the inhibisome. Thus, ITAM suppressive signals subvert the activating function of rafts to promote incorporation of receptors into supramolecular domains where signaling molecules are deactivated by SHP-1.

* E-mail, ivashkivl{at}hss.edu

Citation: L. B. Ivashkiv, How ITAMs Inhibit Signaling. Sci. Signal. 4, pe20 (2011).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Plasmacytoid Dendritic Cells, Interferon Signaling, and Fc{gamma}R Contribute to Pathogenesis and Therapeutic Response in Childhood Immune Thrombocytopenia.
K. Sehgal, X. Guo, S. Koduru, A. Shah, A. Lin, X. Yan, and K. M. Dhodapkar (2013)
Science Translational Medicine 5, 193ra89
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882